According to studies conducted in vivo and in vitro, luteolin can treat sepsis through the destabilization of the heat-shock protein 90 (Hsp90), which destabilizes c-Jun and Akt, thus decreasing the release of HMGB1 and its activation of the inflammatory cascade [147]. The gene discussed is AKT1; the disease is Sepsis.